Compile Data Set for Download or QSAR
maximum 50k data
Found 34 Enz. Inhib. hit(s) with all data for entry = 8421
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247293(US9447090, 12)
Affinity DataEC50:  3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247326(US9447090, 834)
Affinity DataEC50:  4.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247295(US9447090, 119)
Affinity DataEC50:  2.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247296(US9447090, 126)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247297(US9447090, 179)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247298(US9447090, 226)
Affinity DataEC50:  6.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247299(US9447090, 247)
Affinity DataEC50:  2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247300(US9447090, 251)
Affinity DataEC50:  6.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247301(US9447090, 321)
Affinity DataEC50:  4.50E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247302(US9447090, 323)
Affinity DataEC50:  1.30E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247303(US9447090, 341)
Affinity DataEC50:  6.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247304(US9447090, 424)
Affinity DataEC50:  2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247305(US9447090, 430)
Affinity DataEC50:  2.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247306(US9447090, 434)
Affinity DataEC50:  7.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247307(US9447090, 693)
Affinity DataEC50:  1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247308(US9447090, 698)
Affinity DataEC50:  1.90E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247309(US9447090, 699)
Affinity DataEC50:  1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247310(US9447090, 702)
Affinity DataEC50:  6.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247311(US9447090, 704)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247312(US9447090, 705)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247313(US9447090, 706)
Affinity DataEC50:  4.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247314(US9447090, 759)
Affinity DataEC50:  2.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247315(US9447090, 760)
Affinity DataEC50:  5.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247316(US9447090, 766)
Affinity DataEC50:  1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247317(US9447090, 767)
Affinity DataEC50:  3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247318(US9447090, 772)
Affinity DataEC50:  5.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247319(US9447090, 776)
Affinity DataEC50:  1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247320(US9447090, 778)
Affinity DataEC50:  6.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247321(US9447090, 797)
Affinity DataEC50:  8.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247322(US9447090, 798)
Affinity DataEC50:  8.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247323(US9447090, 822)
Affinity DataEC50:  5.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247324(US9447090, 828)
Affinity DataEC50:  7.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247325(US9447090, 829)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma

US Patent
LigandPNGBDBM247294(US9447090, 102)
Affinity DataEC50:  2.80E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent